Nation's Second Participant Enrolls in Human Embryonic Stem Cell Trial

Northwestern Memorial, the Feinberg School and RIC continue to forge collaborative strides in an effort to help people with severe spinal cord injuries

©2010 Rehabilitation Institute of Chicago. All rights reserved.

CHICAGO (May 10,2011) - Researchers at Northwestern Memorial Hospital, Northwestern University Feinberg School of Medicine and The Rehabilitation Institute of Chicago (RIC) recently enrolled their first subject in a national clinical research trial of a human embryonic stem cell-based therapy for participants with a subacute thoracic spinal cord injury. This is only the second enrollment nationwide in the study sponsored by Geron Corp. (Nasdaq: GERN). Northwestern is the lead site of the trial, which will eventually include up to six other sites and enroll up to 10 subjects nationally...

Entire article can be accessed here: Nation's Second Participant Enrolls in Human Embryonic Stem Cell Trial.